GORAN ANDO - 09 Feb 2022 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
09 Feb 2022
Net transactions value
$0
Form type
4
Filing time
11 Feb 2022, 15:48:08 UTC
Previous filing
05 Jan 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +2,750 +128% $0.000000 4,900 09 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +3,250 $0.000000 3,250 09 Feb 2022 Common Stock 3,250 $0.000000 Direct F1
transaction EYPT Restricted Stock Units Options Exercise $0 -2,750 -100% $0.000000* 0 09 Feb 2022 Common Stock 2,750 $0.000000 Direct F2
transaction EYPT Stock Option (Right to Buy) Award $0 +12,000 $0.000000 12,000 09 Feb 2022 Common Stock 12,000 $10.13 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Will fully vest on the one-year anniversary of the grant date.
F2 Fully vested on the one-year anniversary of the grant date.